TOPIC: Obstructive Lung Diseases TYPE: Fellow Case Reports INTRODUCTION: Pneumomediastinum is usually caused by a dissection of air from alveolar-pleural communications or the introduction of air from other intrathoracic (e.g., esophageal, tracheal, bronchial) or extrathoracic sources. We describe a case of Vaping-associated asthma exacerbation presenting as spontaneous pneumomediastinum (SPM). CASE PRESENTATION: The patient is a 19-year-old male with high functioning cerebral palsy, epilepsy, daily inhalational nicotine, and marijuana use presented with dyspnea, pleuritic chest, and right neck pain. He had presented to the emergency department two days prior to this admission with dyspnea and wheezing. At that time, he was empirically treated for asthma exacerbation with albuterol nebulization and IV steroids with improvement in symptoms despite no prior formal diagnosis of asthma. Upon discharge, he started using an electronic nicotine vape in an attempt to quit smoking cigarettes. He continued to have dyspnea and spontaneously developed new chest and neck pain, which prompted him to revisit the ER for further evaluation. He claimed that he did not take his medications as prescribed on discharge. His chest radiography showed hyperinflated lungs with new subcutaneous air in the right neck compared to previous imaging. He denied any violent cough, vomiting, or retching prior to arrival. At presentation, he was afebrile, tachycardia(108 bpm), normal respiratory rate(20), and had an oxygen saturation of 94% on room air. He had nasal tone, bilateral diffuse expiratory wheezing, and crackles on palpation on the upper chest and neck. His initial blood gas showed hypercapnia, prompting ICU admission for closer monitoring. His CT chest with oral contrast showed subcutaneous emphysema in the neck and pneumomediastinum with no extravasation of contrast from the esophagus. His lab work showed positive rhinovirus PCR, elevated eosinophil levels, IgE levels, and a positive RAST panel for dust mites. He was treated with supplemental oxygen, bronchodilators, and steroids with improvement in clinical and imaging findings. Spirometry prior to discharge showed airflow obstruction consistent with the working diagnosis of asthma. He was discharged on ICS/LABA inhaler therapy with PRN albuterol for shortness of breath. DISCUSSION: E-Vaping, even for purposes of smoking cessation, can be detrimental during an asthma exacerbation. We believe the combination of air trapping due to bronchoconstriction in the setting of asthma exacerbation and rapid and large volume inhalation of an electronic cigarette can lead to an abrupt increase in the intra-alveolar pressure resulting in alveolar rupture. This released alveolar air dissects centripetally through the pulmonary interstitium along the bronchovascular sheaths toward the pulmonary hila into the mediastinum, causing SPM. CONCLUSIONS: The learning objective is vaping can increase the risk of SPM in the setting of asthma exacerbation. REFERENCE #1: S. Faruqi, R. Varma, M.A. Greenstone & J.A. Kastelik (2009) Spontaneous Pneumomediastinum: A Rare Complication of Bronchial Asthma, Journal of Asthma, 46:9, 969-971, DOI: 10.3109/02770900903215635 DISCLOSURES: No relevant relationships by Rajesh Kunadharaju, source=Web Response No relevant relationships by Alberto Monegro, source=Web Response No relevant relationships by Ryan Salemme, source=Web Response No relevant relationships by Kathyayini Tappeta, source=Web Response
Read full abstract